Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TET1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | KIAA1456 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | LDHB | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | ZNF460 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | NDUFC1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | RP11-216L13.16 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | C2orf54 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | NIT1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PIK3R2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ICA1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |